Literature DB >> 9466322

Human plasma leptin in obese subjects and diabetics.

Y Tasaka1, K Yanagisawa, Y Iwamoto.   

Abstract

Leptin is the protein product of the ob gene, an adipocyte-specific gene, recently discovered in mice. Plasma leptin levels were determined in six normals, twenty-one subjects with impaired glucose tolerance, and forty-nine untreated NIDDM subjects. They increased with the augmentation of obesity (body mass index, BMI kg/m2) and were higher in females than in males: in BMI less than 25 kg/m2 the values of plasma leptin were 2.24 +/- 0.25 ng/ml (n=29) in males and 3.01 +/- 0.39 ng/ml (n=13) in females (P<0.054), respectively, in BMI between 25 kg/m2 and 30 kg/m2 they were 3.14 +/- 0.31 ng/ml (n=10) in males and 10.66 +/- 2.86 ng/ml (n=7) in females (P<0.0018) and in BMI higher than 30 kg/m2 their levels were 8.98 +/- 1.5 ng/ml (n=11) and 11.74 +/- 2.2 ng/ml (n=6) (P<0.23), respectively. The severity of diabetes mellitus judged from the fasting plasma glucose level had no influence on the plasma leptin levels during OGTT, but the leptin levels decreased significantly during a tolerance test (P<0.001), and similar results were also seen during a breakfast test. The fasting plasma leptin in the male with FBS less than 140 mg/dl had a significant correlation with the fasting plasma IRI level, but this correlation disappeared after taking obesity into consideration. Thus the plasma leptin was chiefly dependent on the body weight and gender and had no special relation to diabetic severity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9466322     DOI: 10.1507/endocrj.44.671

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

1.  Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament.

Authors:  Yoshikazu Ikeda; Arata Nakajima; Atsuomi Aiba; Masao Koda; Akihiko Okawa; Kazuhisa Takahashi; Masashi Yamazaki
Journal:  Eur Spine J       Date:  2011-01-22       Impact factor: 3.134

Review 2.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

Review 3.  Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes?

Authors:  Milagros Gloria Huerta
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

4.  Serum leptin level is reduced in non-obese subjects with type 2 diabetes.

Authors:  Ghorban Mohammadzadeh; Nosratollah Zarghami
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

5.  Leptin levels in obese women with and without type 2 diabetes mellitus.

Authors:  Mehmet Akif Buyukbese; Ali Cetinkaya; Ramazan Kocabas; Aytekin Guven; Mehmet Tarakcioglu
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

6.  Association between plasma leptin level and systemic inflammatory markers in patients with aggressive periodontitis.

Authors:  Dong Shi; Yun-Yu Liu; Wei Li; Xin Zhang; Xiao-Jun Sun; Li Xu; Li Zhang; Zhi-Bin Chen; Huan-Xin Meng
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

Review 7.  Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies.

Authors:  Amitabha Ray
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.